FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Intramuscular administration of a synthetic CpG-oligodeoxynu...
PloS one2014; 9(10); e109865; doi: 10.1371/journal.pone.0109865

Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals.

Abstract: Neutrophils play an important role in protecting against infection. Foals have age-dependent deficiencies in neutrophil function that may contribute to their predisposition to infection. Thus, we investigated the ability of a CpG-ODN formulated with Emulsigen to modulate functional responses of neutrophils in neonatal foals. Eighteen foals were randomly assigned to receive either a CpG-ODN with Emulsigen (N = 9) or saline intramuscularly at ages 1 and 7 days. At ages 1, 3, 9, 14, and 28, blood was collected and neutrophils were isolated from each foal. Neutrophils were assessed for basal and Rhodococcus equi-stimulated mRNA expression of the cytokines interferon-γ (IFN-γ), interleukin (IL)-4, IL-6, and IL-8 using real-time PCR, degranulation by quantifying the amount of β-D glucuronidase activity, and reactive oxygen species (ROS) generation using flow cytometry. In vivo administration of the CpG-ODN formulation on days 1 and 7 resulted in significantly (P<0.05) increased IFN-γ mRNA expression by foal neutrophils on days 3, 9, and 14. Degranulation was significantly (P<0.05) lower for foals in the CpG-ODN-treated group than the control group at days 3 and 14, but not at other days. No effect of treatment on ROS generation was detected. These results indicate that CpG-ODN administration to foals might improve innate and adaptive immune responses that could protect foals against infectious diseases and possibly improve responses to vaccination.
Get Full Text
Publication Date: 2014-10-15 PubMed ID: 25333660PubMed Central: PMC4198146DOI: 10.1371/journal.pone.0109865Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses a study investigating the effect of a synthetic CpG-oligodeoxynucleotide (CpG-ODN) on the immune responses of newborn horses (foals). The researchers discovered that administering CpG-ODN enhanced the immune responses of the neutrophils in foals which could protect them from infectious diseases and improve responses to vaccination.

Research Context and Method

  • Neutrophils which are a type of white blood cell, play a vital role in the immune system’s mechanism for fighting off infections. This research explores a potential method for enhancing the functionality of these neutrophils in newborn horses, who often exhibit age-dependent deficiencies in their immune responses.
  • The researchers used a synthetic CpG-ODN in combination with Emulsigen, an adjuvant that enhances the body’s immune response, administered intramuscularly at two different stages of the foals’ early life – day one and day seven.
  • In order to evaluate the effects of the treatment, the researchers isolated neutrophils from blood samples taken from the foals at different ages post-treatment (day 1, 3, 9, 14, and 28). These neutrophils were then assessed for their functionality in various ways.

Findings and Results

  • Effects of the CpG-ODN treatments on the neutrophils’ functional responses were identified in a few key areas. Most prominently, it was found that interferon-γ (IFN-γ), a type of protein that helps stimulate the immune system, had significantly increased mRNA expression in treated foals.
  • These significant increases were observed on days 3, 9 and 14 post-treatment, indicating an enhanced immune response during these periods.
  • Additionally, degranulation, the process by which neutrophils release antimicrobial molecules, was significantly lower in treated foals compared to the control group on days 3 and 14. This suggests that CpG-ODN treatment possibly leads to a more controlled and efficient use of these cell resources.
  • However, the researchers did not observe any changes in the generation of reactive oxygen species (ROS), molecules that play a role in cell signaling and homeostasis.

Implications of the Research

  • The findings present potential for using CpG-ODN treatment to augment immune responses in newborn horses, which could offer better protection against infectious diseases.
  • Additionally, it may also improve responses to vaccination, thus broadening the implications beyond natural disease resistance.

Cite This Article

APA
Cohen ND, Bourquin JR, Bordin AI, Kuskie KR, Brake CN, Weaver KB, Liu M, Felippe MJ, Kogut MH. (2014). Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals. PLoS One, 9(10), e109865. https://doi.org/10.1371/journal.pone.0109865

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 9
Issue: 10
Pages: e109865
PII: e109865

Researcher Affiliations

Cohen, Noah D
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Bourquin, Jessica R
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Bordin, Angela I
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Kuskie, Kyle R
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Brake, Courtney N
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Weaver, Kaytee B
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Liu, Mei
  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
Felippe, M Julia B
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Kogut, Michael H
  • Food and Feed Safety Research, Agricultural Research Service, Southern Plains Agricultural Research Center, USDA, College Station, Texas, United States of America.

MeSH Terms

  • Animals
  • Animals, Newborn
  • Cytokines / genetics
  • Cytokines / metabolism
  • Female
  • Gene Expression Regulation / drug effects
  • Horses
  • Injections, Intramuscular
  • Male
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Neutrophils / metabolism
  • Oligodeoxyribonucleotides / administration & dosage
  • Reactive Oxygen Species / metabolism

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 51 references
  1. Giguère S, Cohen ND, Chaffin MK, Slovis NM, Hondalus MK, Hines SA, Prescott JF. Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals.. J Vet Intern Med 2011 Nov-Dec;25(6):1209-20.
    pubmed: 22092608doi: 10.1111/j.1939-1676.2011.00835.xgoogle scholar: lookup
  2. Magdesian KG, Hirsh DC, Jang SS, Hansen LM, Madigan JE. Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997).. J Am Vet Med Assoc 2002 Jan 1;220(1):67-73.
    pubmed: 12680451doi: 10.2460/javma.2002.220.67google scholar: lookup
  3. East LM, Dargatz DA, Traub-Dargatz JL, Savage CJ. Foaling-management practices associated with the occurrence of enterocolitis attributed to Clostridium perfringens infection in the equine neonate.. Prev Vet Med 2000 Jul 3;46(1):61-74.
    pubmed: 10854936doi: 10.1016/s0167-5877(00)00131-8google scholar: lookup
  4. Frederick J, Giguère S, Sanchez LC. Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003-2008).. J Vet Intern Med 2009 Nov-Dec;23(6):1254-60.
    pmc: PMC7166729pubmed: 19747192doi: 10.1111/j.1939-1676.2009.0383.xgoogle scholar: lookup
  5. Burton AJ, Nydam DV, Dearen TK, Mitchell K, Bowman DD, Xiao L. The prevalence of Cryptosporidium, and identification of the Cryptosporidium horse genotype in foals in New York State.. Vet Parasitol 2010 Nov 24;174(1-2):139-44.
    pubmed: 20932647doi: 10.1016/j.vetpar.2010.08.019google scholar: lookup
  6. Marsh PS, Palmer JE. Bacterial isolates from blood and their susceptibility patterns in critically ill foals: 543 cases (1991-1998).. J Am Vet Med Assoc 2001 May 15;218(10):1608-10.
    pubmed: 11393374doi: 10.2460/javma.2001.218.1608google scholar: lookup
  7. Corley KT, Pearce G, Magdesian KG, Wilson WD. Bacteraemia in neonatal foals: clinicopathological differences between Gram-positive and Gram-negative infections, and single organism and mixed infections.. Equine Vet J 2007 Jan;39(1):84-9.
    pubmed: 17228602doi: 10.2746/042516407x157585google scholar: lookup
  8. Cohen ND. Causes of and farm management factors associated with disease and death in foals.. J Am Vet Med Assoc 1994 May 15;204(10):1644-51.
    pubmed: 8050947
  9. Anonymous. Part I: Baseline Reference of 1998 Equine Health Management. USDA-APHIS, Veterinary Services Report pp. 34–46.
  10. Cuenca AG, Wynn JL, Moldawer LL, Levy O. Role of innate immunity in neonatal infection.. Am J Perinatol 2013 Feb;30(2):105-12.
    pmc: PMC3959733pubmed: 23297181doi: 10.1055/s-0032-1333412google scholar: lookup
  11. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates.. Nat Rev Immunol 2007 May;7(5):379-90.
    pubmed: 17457344doi: 10.1038/nri2075google scholar: lookup
  12. Jaillon S, Galdiero MR, Del Prete D, Cassatella MA, Garlanda C, Mantovani A. Neutrophils in innate and adaptive immunity.. Semin Immunopathol 2013 Jul;35(4):377-94.
    pubmed: 23553214doi: 10.1007/s00281-013-0374-8google scholar: lookup
  13. Martens RJ, Cohen ND, Jones SL, Moore TA, Edwards JF. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi.. Infect Immun 2005 Oct;73(10):7040-2.
    pmc: PMC1230988pubmed: 16177388doi: 10.1128/iai.73.10.7040-7042.2005google scholar: lookup
  14. Chaffin MK, Cohen ND, Martens RJ, Edwards RF, Nevill M, Smith R 3rd. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection.. Vet Immunol Immunopathol 2004 Jul;100(1-2):33-48.
    pubmed: 15182994doi: 10.1016/j.vetimm.2004.02.010google scholar: lookup
  15. Koenig JM, Yoder MC. Neonatal neutrophils: the good, the bad, and the ugly.. Clin Perinatol 2004 Mar;31(1):39-51.
    pubmed: 15183655doi: 10.1016/j.clp.2004.03.013google scholar: lookup
  16. Wichtel MG, Anderson KL, Johnson TV, Nathan U, Smith L. Influence of age on neutrophil function in foals.. Equine Vet J 1991 Nov;23(6):466-9.
    pubmed: 1778167doi: 10.1111/j.2042-3306.1991.tb03763.xgoogle scholar: lookup
  17. Gröndahl G, Johannisson A, Demmers S, Jensen Waern M. Influence of age and plasma treatment on neutrophil phagocytosis and CD18 expression in foals.. Vet Microbiol 1999 Mar 12;65(3):241-54.
    pubmed: 10189199doi: 10.1016/s0378-1135(98)00299-5google scholar: lookup
  18. Flaminio MJ, Rush BR, Davis EG, Hennessy K, Shuman W, Wilkerson MJ. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals.. Vet Immunol Immunopathol 2000 Mar 15;73(3-4):267-85.
    pubmed: 10713340doi: 10.1016/s0165-2427(00)00149-5google scholar: lookup
  19. Dawson DR, Nydam DV, Price CT, Graham JE, Cynamon MH, Divers TJ, Felippe MJ. Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activation.. Am J Vet Res 2011 Nov;72(11):1465-75.
    pubmed: 22023124doi: 10.2460/ajvr.72.11.1465google scholar: lookup
  20. Martens JG, Martens RJ, Renshaw HW. Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses.. Am J Vet Res 1988 Mar;49(3):295-9.
    pubmed: 3358541
  21. McTaggart C, Yovich JV, Penhale J, Raidal SL. A comparison of foal and adult horse neutrophil function using flow cytometric techniques.. Res Vet Sci 2001 Aug;71(1):73-9.
    pubmed: 11666151doi: 10.1053/rvsc.2001.0490google scholar: lookup
  22. Nerren JR, Martens RJ, Payne S, Murrell J, Butler JL, Cohen ND. Age-related changes in cytokine expression by neutrophils of foals stimulated with virulent Rhodococcus equi in vitro.. Vet Immunol Immunopathol 2009 Feb 15;127(3-4):212-9.
    pubmed: 19026456doi: 10.1016/j.vetimm.2008.10.004google scholar: lookup
  23. Bordin AI, Liu M, Nerren JR, Buntain SL, Brake CN, Kogut MH, Cohen ND. Neutrophil function of neonatal foals is enhanced in vitro by CpG oligodeoxynucleotide stimulation.. Vet Immunol Immunopathol 2012 Jan 15;145(1-2):290-7.
    pubmed: 22197007doi: 10.1016/j.vetimm.2011.11.012google scholar: lookup
  24. Liu M, Liu T, Bordin A, Nerren J, Cohen N. Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi.. Cytokine 2009 Dec;48(3):280-9.
    pubmed: 19819162doi: 10.1016/j.cyto.2009.08.012google scholar: lookup
  25. Alves MP, Guzylack-Piriou L, Juillard V, Audonnet JC, Doel T, Dawson H, Golde WT, Gerber H, Peduto N, McCullough KC, Summerfield A. Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigs.. Clin Vaccine Immunol 2009 Aug;16(8):1151-7.
    pmc: PMC2725537pubmed: 19553550doi: 10.1128/cvi.00018-09google scholar: lookup
  26. Ioannou XP, Griebel P, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.. J Virol 2002 Sep;76(18):9002-10.
    pmc: PMC136463pubmed: 12186884doi: 10.1128/jvi.76.18.9002-9010.2002google scholar: lookup
  27. Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van Drunen Littel-van den Hurk S. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.. J Virol 2005 Feb;79(4):2024-32.
    pmc: PMC546558pubmed: 15681404doi: 10.1128/jvi.79.4.2024-2032.2005google scholar: lookup
  28. Nichani AK, Mena A, Popowych Y, Dent D, Townsend HG, Mutwiri GK, Hecker R, Babiuk LA, Griebel PJ. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep.. Vet Immunol Immunopathol 2004 Mar;98(1-2):17-29.
    pubmed: 15127838doi: 10.1016/j.vetimm.2003.10.001google scholar: lookup
  29. Nichani AK, Kaushik RS, Mena A, Popowych Y, Dent D, Townsend HG, Mutwiri G, Hecker R, Babiuk LA, Griebel PJ. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep.. Cell Immunol 2004 Jan;227(1):24-37.
    pubmed: 15051512doi: 10.1016/j.cellimm.2004.01.004google scholar: lookup
  30. Vordermeier HM, Pontarollo R, Karvonen B, Cockle P, Hecker R, Singh M, Babiuk LA, Hewinson RG, van Drunen Littel-van Den Hurk S. Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c.. Vaccine 2005 Aug 15;23(35):4375-84.
    pubmed: 15908057doi: 10.1016/j.vaccine.2005.04.022google scholar: lookup
  31. Wedlock DN, Skinner MA, de Lisle GW, Vordermeier HM, Hewinson RG, Hecker R, van Drunen Littel-van den Hurk S, Babiuk LA, Buddle BM. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.. Vet Immunol Immunopathol 2005 Jun 15;106(1-2):53-63.
    pubmed: 15910992doi: 10.1016/j.vetimm.2005.01.002google scholar: lookup
  32. Wedlock DN, Denis M, Skinner MA, Koach J, de Lisle GW, Vordermeier HM, Hewinson RG, van Drunen Littel-van den Hurk S, Babiuk LA, Hecker R, Buddle BM. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.. Infect Immun 2005 Jun;73(6):3540-6.
    pmc: PMC1111861pubmed: 15908383doi: 10.1128/iai.73.6.3540-3546.2005google scholar: lookup
  33. Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, Townsend HG. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.. Vet Immunol Immunopathol 2006 Nov 15;114(1-2):103-10.
    pubmed: 16950519doi: 10.1016/j.vetimm.2006.07.013google scholar: lookup
  34. Mutwiri GK, Nichani AK, Babiuk S, Babiuk LA. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.. J Control Release 2004 May 31;97(1):1-17.
    pubmed: 15147800doi: 10.1016/j.jconrel.2004.02.022google scholar: lookup
  35. Shafique M, Wilschut J, de Haan A. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.. Vaccine 2012 Jan 11;30(3):597-606.
    pubmed: 22120195doi: 10.1016/j.vaccine.2011.11.054google scholar: lookup
  36. Boyd NK, Cohen ND, Lim WS, Martens RJ, Chaffin MK, Ball JM. Temporal changes in cytokine expression of foals during the first month of life.. Vet Immunol Immunopathol 2003 Mar 20;92(1-2):75-85.
    pubmed: 12628765doi: 10.1016/s0165-2427(03)00021-7google scholar: lookup
  37. Breathnach CC, Sturgill-Wright T, Stiltner JL, Adams AA, Lunn DP, Horohov DW. Foals are interferon gamma-deficient at birth.. Vet Immunol Immunopathol 2006 Aug 15;112(3-4):199-209.
    pubmed: 16621024doi: 10.1016/j.vetimm.2006.02.010google scholar: lookup
  38. Liu M, Bordin A, Liu T, Russell K, Cohen N. Gene expression of innate Th1-, Th2-, and Th17-type cytokines during early life of neonatal foals in response to Rhodococcus equi.. Cytokine 2011 Nov;56(2):356-64.
    pubmed: 21835631doi: 10.1016/j.cyto.2011.07.017google scholar: lookup
  39. Liu T, Nerren J, Liu M, Martens R, Cohen N. Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals.. Vaccine 2009 Jan 29;27(5):674-83.
    pubmed: 19056444doi: 10.1016/j.vaccine.2008.11.040google scholar: lookup
  40. Sumino K, Tucker J, Shahab M, Jaffee KF, Visness CM, Gern JE, Bloomberg GR, Holtzman MJ. Antiviral IFN-γ responses of monocytes at birth predict respiratory tract illness in the first year of life.. J Allergy Clin Immunol 2012 May;129(5):1267-1273.e1.
    pmc: PMC3340511pubmed: 22460071doi: 10.1016/j.jaci.2012.02.033google scholar: lookup
  41. Yamaguchi Y, Harker JA, Wang B, Openshaw PJ, Tregoning JS, Culley FJ. Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.. J Virol 2012 Oct;86(19):10456-61.
    pmc: PMC3457284pubmed: 22811525doi: 10.1128/jvi.01082-12google scholar: lookup
  42. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, Teles R, Montoya D, Iyer SS, Bruns H, Lewinsohn DM, Hollis BW, Hewison M, Adams JS, Steinmeyer A, Zügel U, Cheng G, Jo EK, Bloom BR, Modlin RL. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.. Sci Transl Med 2011 Oct 12;3(104):104ra102.
    pmc: PMC3269210pubmed: 21998409doi: 10.1126/scitranslmed.3003045google scholar: lookup
  43. Brandt E, Woerly G, Younes AB, Loiseau S, Capron M. IL-4 production by human polymorphonuclear neutrophils.. J Leukoc Biol 2000 Jul;68(1):125-30.
    pubmed: 10914499
  44. Snoeck HW, Lardon F, Lenjou M, Nys G, Van Bockstaele DR, Peetermans ME. Interferon-gamma and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells.. Eur J Immunol 1993 May;23(5):1072-7.
    pubmed: 7682957doi: 10.1002/eji.1830230514google scholar: lookup
  45. Bober LA, Waters TA, Pugliese-Sivo CC, Sullivan LM, Narula SK, Grace MJ. IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils.. Clin Exp Immunol 1995 Jan;99(1):129-36.
    pmc: PMC1534134pubmed: 7529148doi: 10.1111/j.1365-2249.1995.tb03483.xgoogle scholar: lookup
  46. Girard D, Paquin R, Beaulieu AD. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.. Biochem J 1997 Jul 1;325 ( Pt 1)(Pt 1):147-53.
    pmc: PMC1218539pubmed: 9224640doi: 10.1042/bj3250147google scholar: lookup
  47. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation.. Microbes Infect 2003 Nov;5(14):1317-27.
    pubmed: 14613775doi: 10.1016/j.micinf.2003.09.008google scholar: lookup
  48. Harvey JW, Asquith RL, McNulty PK, Kivipelto J, Bauer JE. Haematology of foals up to one year old.. Equine Vet J 1984 Jul;16(4):347-53.
    pubmed: 6479131doi: 10.1111/j.2042-3306.1984.tb01940.xgoogle scholar: lookup
  49. Kirby AC, Yrlid U, Wick MJ. The innate immune response differs in primary and secondary Salmonella infection.. J Immunol 2002 Oct 15;169(8):4450-9.
    pubmed: 12370380doi: 10.4049/jimmunol.169.8.4450google scholar: lookup
  50. Yin J, Ferguson TA. Identification of an IFN-gamma-producing neutrophil early in the response to Listeria monocytogenes.. J Immunol 2009 Jun 1;182(11):7069-73.
    pmc: PMC2685461pubmed: 19454704doi: 10.4049/jimmunol.0802410google scholar: lookup
  51. Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM, Standiford TJ. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection.. J Immunol 2004 Oct 15;173(8):5148-55.
    pmc: PMC3001228pubmed: 15470059doi: 10.4049/jimmunol.173.8.5148google scholar: lookup

Citations

This article has been cited 8 times.
  1. Cohen ND, Kahn SK, Cywes-Bentley C, Ramirez-Cortez S, Schuckert AE, Vinacur M, Bordin AI, Pier GB. Serum Antibody Activity against Poly-N-Acetyl Glucosamine (PNAG), but Not PNAG Vaccination Status, Is Associated with Protecting Newborn Foals against Intrabronchial Infection with Rhodococcus equi. Microbiol Spectr 2021 Sep 3;9(1):e0063821.
    doi: 10.1128/Spectrum.00638-21pubmed: 34319137google scholar: lookup
  2. Bordin AI, Cohen ND, Giguère S, Bray JM, Berghaus LJ, Scott B, Johnson R, Hook M. Host-directed therapy in foals can enhance functional innate immunity and reduce severity of Rhodococcus equi pneumonia. Sci Rep 2021 Jan 28;11(1):2483.
    doi: 10.1038/s41598-021-82049-ypubmed: 33510265google scholar: lookup
  3. Folmar CN, Cywes-Bentley C, Bordin AI, Rocha JN, Bray JM, Kahn SK, Schuckert AE, Pier GB, Cohen ND. In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly-N-acetyl glucosamine hyperimmune plasma compared to commercial plasma products. J Vet Intern Med 2019 May;33(3):1493-1499.
    doi: 10.1111/jvim.15511pubmed: 31034109google scholar: lookup
  4. Morris MC, Nadeem Khan M, Pichichero ME. A PCR-based method for quantifying neutrophils in human nasal secretions. J Immunol Methods 2017 Aug;447:65-70.
    doi: 10.1016/j.jim.2017.04.010pubmed: 28454715google scholar: lookup
  5. Morris MC, Surendran N. Neonatal Vaccination: Challenges and Intervention Strategies. Neonatology 2016;109(3):161-9.
    doi: 10.1159/000442460pubmed: 26757146google scholar: lookup
  6. Whitfield-Cargile CM, Cohen ND, Suchodolski J, Chaffin MK, McQueen CM, Arnold CE, Dowd SE, Blodgett GP. Composition and Diversity of the Fecal Microbiome and Inferred Fecal Metagenome Does Not Predict Subsequent Pneumonia Caused by Rhodococcus equi in Foals. PLoS One 2015;10(8):e0136586.
    doi: 10.1371/journal.pone.0136586pubmed: 26305682google scholar: lookup
  7. da Silveira BP, Kahn SK, Legere RM, Bray JM, Cole-Pfeiffer HM, Golding MC, Cohen ND, Bordin AI. Enteral immunization with live bacteria reprograms innate immune cells and protects neonatal foals from pneumonia. Sci Rep 2025 May 25;15(1):18156.
    doi: 10.1038/s41598-025-02060-5pubmed: 40415003google scholar: lookup
  8. da Silveira BP, Cohen ND, Lawhon SD, Watson RO, Bordin AI. Protective immune response against Rhodococcus equi: An innate immunity-focused review. Equine Vet J 2025 May;57(3):563-586.
    doi: 10.1111/evj.14214pubmed: 39258739google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.